IP Library Granted Patent US 10,202,607
Granted Patent B2
US 10,202,607 · App. 15/767,901 · Granted Feb 12, 2019

Cleavable fusion tag for protein overexpression and purification

Inventors: Stewart N. Loh (Manlius, NY); Jeung-Hoi Ha (Manlius, NY); Adam R. Blanden (Manlius, NY); Alan Blayney (Syracuse, NY)
Assignee: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
C12N15/62C07K19/00C12N15/65C12N15/66C12N15/70C12N15/74C12N15/79C07K2319/50C12N2310/3517C12N2310/3519C12N2510/02C12N2810/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,202,607
App. No.
15/767,901
Granted
Feb 12, 2019
Kind
B2
Abstract

Provided are compositions and methods for enhancing recombinant protein production. The compositions and methods involve use of Ribose Binding Protein (RBP) as a segment of a fusion polypeptide, whereby the RBP segment enhances production of the fusion protein. The fusion proteins contain the RBP sequentially in a single fusion protein with a polypeptide for which enhanced expression is desired. Recombinant expression vectors encoding the fusion proteins that contain and RBP segment are included, as are cells that contain the expression vectors. Methods for separating fusion proteins and for liberating a polypeptide segment that is part of the fusion protein are also provided.

Claims (20)

1. A recombinant expression vector encoding a fusion protein comprising sequentially a Ribose Binding Protein (RBP) segment and an uninterrupted target polypeptide, wherein the RBP segment comprises at least 178 contiguous amino acids of SEQ ID NO:2, wherein the segment comprises amino acid number 34 (Gly) of SEQ ID NO:2 and amino acid number 211 (Gln) of SEQ ID NO:2, and wherein the expression vector does not encode a signal peptide that targets the fusion protein to periplasm.

2. The recombinant expression vector of claim 1 , wherein an amino acid linker sequence is encoded between the RBP segment and the target protein.

3. The recombinant expression vector of claim 1 , further encoding at least one amino acid sequence tag for purification of the encoded fusion protein.

4. The recombinant expression vector of claim 1 , wherein the target protein is the only target protein encoded by the expression vector or the RBP segment is the only RBP segment encoded by the expression vector.

5. The recombinant expression vector of claim 2 , wherein the amino acid linker sequence comprises a proteolytic cleavage site.

6. The recombinant expression vector of claim 1 , wherein the fusion protein encoded by the expression vector does not oligomerize in solution with proteins that have the same amino acid sequence of the fusion protein encoded by the expression vector.

7. A method of making a recombinant fusion protein, the method comprising allowing an expression vector of claim 1 to express the fusion protein in cells in a cell culture, and subsequently separating the fusion protein from the cell culture.

8. The method of claim 7 , wherein the fusion protein is expressed in a greater amount than a control, the control comprising a value for expression of the target protein by an expression vector that encodes the uninterrupted target polypeptide but does not encode the Ribose Binding Protein (RBP) segment.

9. The method of claim 7 wherein the expression vector encodes the proteolytic cleavage site, the method further comprising cleaving the fusion protein at the proteolytic cleavage site and separating the target polypeptide from the RBD segment.

10. The method of claim 7 , wherein the cell culture is one of a eukaryotic cell culture and a prokaryotic cell culture.

11. A method of making a cell culture for recombinant fusion protein expression, the method comprising introducing an expression vector of claim 1 into cells in the cell culture.

12. The method of claim 11 , wherein the cell culture is a prokaryotic cell culture.

13. The method of claim 11 , wherein the cell culture is a eukaryotic cell culture.

14. An in vitro cell culture comprising one or more cells which comprise an expression vector of claim 1 .

15. The in vitro cell culture of claim 14 , further comprising a culture medium.

16. The in vitro cell culture of claim 14 , wherein the one or more cells which comprise an expression vector of claim 1 are lysed.

17. A kit comprising an expression vector, the expression vector encoding a Ribose Binding Protein (RBP) segment and a restriction endonuclease recognition site configured for insertion of a polynucleotide encoding the open reading frame of a target protein so that the target protein is expressed in a fusion protein with the RBP, wherein the RBP segment comprises at least 178 contiguous amino acids of SEQ ID NO:2, wherein the segment comprises amino acid number 35 (Gly) of SEQ ID NO:2 and amino acid number 211 (Gln) of SEQ ID NO:2, wherein the open reading frame of the target protein is not within a sequence encoding the RBP segment.

18. The kit of claim 17 , further comprising a restriction endonuclease that recognizes the restriction endonuclease recognition site.

19. The kit of claim 17 , wherein the expression vector does not encode a signal peptide that targets the fusion protein to periplasm.

20. The kit of claim 17 , further comprising printed instructions for using the expression vector to express the fusion protein.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 2, 2022
From: STATE UNIVERSITY OF NEW YORK
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 060693/0367 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2018
From: LOH, STEWART N; HA, JEUNG-HOI; BLANDEN, ADAM R; BLAYNEY, ALAN
To: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
Reel/Frame 045551/0309 →
Continuity (2)
Provisional Application 62240863 · Oct 13, 2015
Related Publication 20180305700A1 · Oct 25, 2018